-
TIME
TOPIC
Sunday, June 15, 2025
-
12:00 – 13:00
Registration
-
13:00 – 13:25
Opening Remark - Cross-border Licensing Trends
Speaker:
David Chen, Managing Director, BFC Group
-
13:25 – 13:50
Keynote Speech – One
Speaker:
TBD
-
13:50 – 14:15
Keynote Speech – Two
Speaker:
Henry He, Partner, Fangda Partners
-
14:15 – 14:30
Coffee Break
-
14:30 – 15:30
Panel 1 - Biopharma Investment Landscape: What’s Driving Deals in 2025 and Beyond?
Moderator:
Michael Tung, ChiefFinancial Officer, vTv Therapeutics
Distinguished Speakers:
Grace Han McMahon, Associate Vice President and Head, Pacific Business Development & Licensing, MSD
Venkatesan Raghavan, Executive Director Search & Evaluation – Oncology, Novartis
Tomohiro Yamauchi, Executive Director, Global Head of Scouting & Transaction Oncology, Astellas
Johan Verbeeck, Vice President Business Development, Oncology, Johnson & Johnson Innovative Medicine
Toby Freyman, Vice President, Business Development, Alexion Pharmaceuticals
-
15:30 – 15:45
Coffee Break
-
15:45 – 16:45
Panel 2 - Maximizing Global Value from Asia’s Early-Stage Biotech Innovation
Distinguished Speakers:
Maha Radhakrishnan, Executive Partner, Sofinnova Investments
Christopher Hupp, Senior Director, External Innovation, Chemistry, Ipsen
Harish Soundararajan, Vice President, Roivant Sciences
Dan Zheng, Senior Director for Oncology Business Development，Center for External Innovation, Takeda
-
16:45 – 17:45
Panel 3 - The Rise of China Biotech: Why Global Pharma is Betting Big?
Distinguished Speakers:
Cynthia Wang, Director, Global Business Development, Asia-Pacific Region, Servier
Josh Shin, Partner, Fangda Partners
